Microsoft is navigating a study in contrasts this month. On one side, a landmark artificial intelligence deal with England’s National Health Service promises to deliver verified productivity gains across hundreds of thousands of clinical staff. On the other, the company has just rolled out its biggest-ever security update, plugging roughly 200 vulnerabilities in core products that underpin vast corporate and government networks. The two stories, unfolding simultaneously, highlight both the promise and the peril of Microsoft’s sprawling ecosystem—and investors so far are unimpressed.
The NHS Deal That Delivers Real Numbers
NHS England has agreed to equip 505,000 frontline staff with Microsoft 365 Copilot under a contract valued at around £120 million. The agreement is one of the largest generative AI deals ever signed in the UK public sector. It follows a pilot involving more than 30,000 employees across 90 NHS organisations, where AI-powered administrative support saved an average of 43 minutes per person per day—the equivalent of five working weeks per year.
At full scale, the rollout could free up to 400,000 hours of staff time every month. The NHS calculates that even with just 100,000 users, monthly savings would run into the millions of pounds. The first 200,000 users are due to be onboarded within six months, with the remaining 305,000 coming on board by October. Microsoft calls it the largest generative AI deployment in global healthcare to date.
Beyond productivity, the deal includes access to Copilot Studio, allowing NHS organisations to build custom agents for tasks ranging from HR queries and complaint handling to financial analysis. Central development by NHS England will be complemented by bespoke solutions from individual trusts.
Security’s Biggest Patch Day
While the NHS story celebrates artificial intelligence, the security team is fighting fires. This month’s patch cycle is described by researchers as the largest since Microsoft’s program began. More than 30 vulnerabilities are rated critical, including flaws that can be exploited remotely. The total number of addressed weaknesses hovers around 200, depending on counting methodology.
One vulnerability stands out: an Exchange Server flaw already being actively exploited. Attackers can access affected systems over the network without administrator privileges. Microsoft is urging administrators to install the update immediately. The scope is broad, touching Azure components and Active Directory, alongside a new Windows setting designed to protect servers from overload attacks.
Should investors sell immediately? Or is it worth buying Microsoft?
For investors, the volume of bugs matters less than the infrastructure affected. Each incident consumes resources and chips away at the reputation that underpins enterprise trust. The timing is uncomfortable: the stock was already under pressure before the patch news broke.
Azure Cuts in China Add to the Gloom
Across the Pacific, Microsoft is trimming its presence in China. Reports indicate that 200 to 400 Azure positions are being eliminated in Beijing and Shanghai, with affected employees told their roles will end on July 6. Some have been offered relocation to Canada. This is the third round of job cuts in China within two years. Other teams—such as the DevDiv unit and the Microsoft AI group in Shanghai and Suzhou—are reportedly unaffected.
Strong Fundamentals, Weakening Chart
Microsoft’s financial engine remains robust. In the third quarter of fiscal 2026, revenue hit $82.89 billion, up 18.3% year over year. Azure expanded by 40%, while the AI business crossed a $37 billion annualised revenue run rate, a 123% surge. The dividend, now at $0.91 per share quarterly, was paid out today.
Yet the share price tells a different story. The stock changed hands at €344.95, sitting almost 28% below its 52-week high. The relative strength index of 41.1 points to a technically weak picture. Year to date, the shares are down nearly 15% and are trading below key moving averages, confirming a downward trend.
A major factor weighing on sentiment: Microsoft’s capital expenditure plans. For 2026, the company expects to spend roughly $190 billion—61% more than the prior year. CFO Amy Hood cited an extra $25 billion burden from higher component prices. The gap between the AI payoff and the upfront investment leaves analysts cautious.
A Test of Trust
The NHS contract provides something rare in the AI market: independently verified productivity data attached to a committed sum of money. Whether that can shift the calculus between rising Capex and a declining stock price will become clearer once the full rollout reaches October and early efficiency reports land. For now, Microsoft must simultaneously convince corporate clients their systems are secure and demonstrate that its AI investments are translating into genuine returns. The two narratives are running in parallel—and the market is waiting to see which one wins out.
Ad
Microsoft Stock: Buy or Sell?! New Microsoft Analysis from June 11 delivers the answer:
The latest Microsoft figures speak for themselves: Urgent action needed for Microsoft investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 11.
Microsoft: Buy or sell? Read more here...
